This lncRNA participates in the regulation of gene transcription in combination with the polycomb inhibitory complex 2, which was first reported in 2017, and may be a neoplasm biomarker for patients with mantle cell lymphoma [7].The lncRNA ROR1-AS1 has the ability to regulate certain tumors as one of the particular sections of ROR1, which could modulate some human diseases and biological behaviors. This evidence concerns the gene ROR1 and mantle cell lymphoma.